|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8470 EUR | -1.97% |
|
-5.89% | -28.10% |
| 02/06 | NFL Biosciences Releases New Results on NFL-101 and Reaffirms Its Personalized Approach to Smoking Cessation | CI |
| 02/06 | NFL Biosciences validates breakthrough in personalized medicine |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 12.7M | - | - | - | - | - |
| 54.54B | |||||
| 43.86B | |||||
| 22.63B | - | ||||
| 20.7B | - | ||||
| 15.84B |
- Stock Market
- Stocks
- ALNFL Stock
- Charts NFL Biosciences
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
